BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38636400)

  • 1. Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway.
    Ma YL; Xu M; Cen XF; Qiu HL; Guo YY; Tang QZ
    Biomed Pharmacother; 2024 May; 174():116589. PubMed ID: 38636400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.
    Yang S; Ma C; Wu H; Zhang H; Yuan F; Yang G; Yang Q; Jia L; Liang Z; Kang L
    Pharmacol Res; 2020 Mar; 153():104678. PubMed ID: 32014572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
    Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
    J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
    Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
    J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
    Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
    Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
    Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
    Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice.
    Guo Z; Tuo H; Tang N; Liu FY; Ma SQ; An P; Yang D; Wang MY; Fan D; Yang Z; Tang QZ
    Int J Biol Sci; 2022; 18(2):826-840. PubMed ID: 35002528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway.
    Xu C; Xia L; Xu D; Liu Y; Jin P; Zhai M; Mao Y; Wang Y; Wen A; Yang J; Yang L
    J Cell Mol Med; 2024 Jan; 28(2):e18055. PubMed ID: 38113341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function.
    Elrashidy RA; Ibrahim SE
    Toxicol Appl Pharmacol; 2021 Jun; 421():115533. PubMed ID: 33848515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice.
    Huang Q; Chen T; Li J; Wang Y; Shi H; Yu Y; Ji Q; Shen X; Sun T; Shi H; Luo X; Jin B; You Y; Wu B
    J Transl Med; 2024 May; 22(1):494. PubMed ID: 38790051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice.
    Dong L; Li JC; Hu ZJ; Huang XR; Wang L; Wang HL; Ma RCW; Lan HY; Yang SJ
    J Cell Mol Med; 2021 May; 25(10):4860-4869. PubMed ID: 33733577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
    Li L; Chen X; Su C; Wang Q; Li R; Jiao W; Luo H; Tian Y; Tang J; Li X; Liu B; Wang W; Zhang D; Guo S
    Biomed Pharmacother; 2020 Dec; 132():110817. PubMed ID: 33068937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activation.
    Qian J; Zhuang F; Chen Y; Fan X; Wang J; Wang Z; Wang Y; Xu M; Samorodov AV; Pavlov VN; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166369. PubMed ID: 35176461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway.
    Wei H; Bu R; Yang Q; Jia J; Li T; Wang Q; Chen Y
    J Diabetes Res; 2019; 2019():8905917. PubMed ID: 31886288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress.
    Zhang L; Hu C; Jin B; Bai B; Liao J; Jin L; Wang M; Zhu W; Wu X; Zheng L; Xu X; Jiang Y; Wang Y; He Y
    Cardiovasc Drugs Ther; 2024 Jun; 38(3):555-568. PubMed ID: 36662448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
    Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
    Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
    Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
    Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3-Crnde negative feedback in diabetic cardiomyopathy.
    Zheng D; Zhang Y; Hu Y; Guan J; Xu L; Xiao W; Zhong Q; Ren C; Lu J; Liang J; Hou J
    FEBS J; 2019 May; 286(9):1645-1655. PubMed ID: 30748104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.